Tag: #Sars-CoV-2#Plasma

Introduction Atypical Hemolytic Uremic Syndrome (aHUS) is a rare but severe condition that affects the complement system, leading to thrombotic microangiopathy and potential organ damage. Given the complexities of managing aHUS during a SARS-CoV-2 infection, this case study explores the successful use of convalescent plasma therapy in a patient with aHUS and COVID-19. Visit HSPIOA…